Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 11Neoplasm Metastasis 3Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence Free Survival 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Histiocytosis 1Fallopian Tube Neoplasms 1Erythema 1Endometrial Neoplasms 1Edema 1Breast Neoplasms 1Brain Neoplasms 1Advanced Solid Tumors 1

Interventions

Injections 8pembrolizumab 4Pemetrexed 4Carboplatin 4Oxaliplatin 3Leucovorin 3Fluorouracil 3trifluridine tipiracil drug combination 2sotorasib 2fludarabine 2Paclitaxel 2Drug Therapy 2Docetaxel 2Bevacizumab 2zimberelimab 1trametinib 1toripalimab 1tislelizumab 1sacituzumab govitecan 1netrin-1 inhibitor NP137 1cemiplimab 1WW Domain-Containing Oxidoreductase 1SYS6006 COVID-19 vaccine 1Panitumumab 1Irinotecan 1Immune Checkpoint Inhibitors 1Etoposide 1Cyclophosphamide 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Panitumumab × 90 days × Clear all
NCT07172919 2026-05-14

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

Amgen

Phase 2 Recruiting
14 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡